진학프로석·박사 채용 접수 플랫폼

The Brancaccio Lab invites applications from talented, highly motivated and creative postdoctoral scientists to take a leading role in one of the following projects investigating molecular cellular and circuit mechanisms driving circadian dysfunction in pre-clinical models of Alzheimer’s disease (AD).

Today, over 1 million people in the UK are living with dementia and related neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and motor neuron disease (MND). The impact of these incurable and progressive conditions on individuals and their families is devastating. The cost to the economy and public services is large and growing as the UK population ages. However, due to major advances in our understanding of the biology of these diseases, the scientific field is at a tipping point, with the next decade promising to deliver transformative breakthroughs in therapies and a new era of predictive, preventative, and precision medicine for neurodegenerative conditions. The UK is well placed to play a leading role in this revolution due to its scientific strengths in the field, led by the UK Dementia Research Institute (UK DRI) working with our world-class, university-based centres. We are a globally leading multidisciplinary research institute of over 900 staff investigating the spectrum of neurodegenerative disorders causing dementia, driving a step change in our understanding of neurodegeneration, and accelerating the discovery, development and delivery of interventions that will help diagnose, treat, and ultimately prevent dementia. Our principal funder is the Medical Research Council (MRC).

Project: Leveraging circadian clocks to prevent Alzheimer’s disease

In this project, you will develop new molecular tools modifying circadian pathways to prevent/ delay Alzheimer’s disease. This project stems from newly established mouse models and clock molecular targets identified in the Brancaccio Lab. You will perform viral delivery of gene therapy viral vectors, behavioural assessment of sleep-wake cycles and cognition, multiplexed live imaging in brain tissue, combinatorial intersectional genetics, and multivariate statistical analysis of time series to validate new chronotherapeutic interventions in Alzheimer’s disease. Further experience with analyses of large ‘OMICS dataset and advanced molecular biology tools in addition to stereotaxic brain surgery and live imaging will be an element of significant strength for this position. Previous knowledge of circadian biology is desirable but not strictly necessary.